|
HARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.576799801839E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.962299542972E-10 |
| Normal-vs-Stage2 |
5.783700E-03 |
| Normal-vs-Stage3 |
8.789800E-02 |
| Normal-vs-Stage4 |
3.693800E-02 |
| Stage1-vs-Stage2 |
9.288000E-01 |
| Stage1-vs-Stage3 |
3.408800E-01 |
| Stage1-vs-Stage4 |
9.777600E-01 |
| Stage2-vs-Stage3 |
5.042000E-01 |
| Stage2-vs-Stage4 |
9.763800E-01 |
| Stage3-vs-Stage4 |
5.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37300179506406E-11 |
| Normal-vs-AfricanAmerican |
7.93040000000023E-05 |
| Normal-vs-Asian |
1.084760E-01 |
| Caucasian-vs-AfricanAmerican |
7.543800E-02 |
| Caucasian-vs-Asian |
9.038200E-01 |
| AfricanAmerican-vs-Asian |
4.198000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18050014208393E-10 |
| Normal-vs-Female |
1.53271999999705E-05 |
| Male-vs-Female |
6.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.154000E-04 |
| Normal-vs-Extreme_Weight |
1.39710000235382E-08 |
| Normal-vs-Obese |
8.44010000000672E-05 |
| Normal-vs-Extreme_Obese |
7.326200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.010200E-01 |
| Normal_Weight-vs-Obese |
9.912600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.030200E-01 |
| Extreme_Weight-vs-Obese |
3.435600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.492200E-01 |
| Obese-vs-Extreme_Obese |
7.868200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.053600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.05990002832834E-09 |
| Normal-vs-Age(61-80Yrs) |
1.02480002261984E-09 |
| Normal-vs-Age(81-100Yrs) |
4.794300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.462400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.596800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.935800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.249800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.848600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.49547041417009E-12 |
| Normal-VS-Type2 PRCC |
3.50209999999684E-06 |
| Normal-VS-KIRP CIMP |
2.769600E-02 |
| Normal-VS-Unclassified PRCC |
9.965700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.091800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.71729999998149E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.086800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.664890E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.573000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.810600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.633900E-04 |
| Normal-vs-N1 |
5.033700E-02 |
| Normal-vs-N2 |
6.490000E-01 |
| N0-vs-N1 |
5.701800E-01 |
| N0-vs-N2 |
6.157800E-01 |
| N1-vs-N2 |
8.131600E-01 |
|
|
